Bicycle Therapeutics (BCYC) Net Margin Growth (3y) (2021 - 2026)
Bicycle Therapeutics (BCYC) Net Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | -605,951.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -605,951.00 |
| Dec 31, 2025 | 31,485.00 |
| Sep 30, 2025 | 42,880.00 |
| Jun 30, 2025 | -219,765.00 |
| Mar 31, 2025 | 10,515.00 |
| Dec 31, 2024 | -27,112.00 |
| Sep 30, 2024 | -155,968.00 |
| Jun 30, 2024 | 57,823.00 |
| Mar 31, 2024 | 64,011.00 |
| Dec 31, 2023 | -46,797.00 |
| Sep 30, 2023 | -66,845.00 |
| Jun 30, 2023 | 39,736.00 |
| Mar 31, 2023 | 20,514.00 |
| Dec 31, 2022 | -27,345.00 |
| Sep 30, 2022 | 61,183.00 |
| Jun 30, 2022 | 16,510.00 |
| Mar 31, 2022 | -61,223.00 |
| Dec 31, 2021 | -49,902.00 |
| Sep 30, 2021 | 13,901.00 |
| Jun 30, 2021 | -70,377.00 |